DUPILUMAB
dupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes
DUPILUMAB (12313C)
12313C
Manner of administration:Injection
Restriction
Indication: Uncontrolled severe asthma
Treatment phase: Initial treatment 1 - (New patient; or Recommencement of treatment in a new treatment
cycle following a break in PBS subsidised biological medicine therapy)
Restriction
Indication: Uncontrolled severe asthma
Treatment phase: Initial treatment - Initial 2 (Change of treatment)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 2 | # of repeats: 8 | DPMQ: $1,658.74 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Dupixent | |||||